|
|
|
Volumn 24, Issue 2, 1997, Pages 173-186
|
|
Antigen-specific agents in development
a
a
CTEP
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOTOXIN LMB2;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY C2 B8;
MONOCLONAL ANTIBODY CD 19;
MONOCLONAL ANTIBODY HD 37;
MONOCLONAL ANTIBODY LMB 1;
MONOCLONAL ANTIBODY LMB 7;
MONOCLONAL ANTIBODY RFB 4;
PACLITAXEL;
PSEUDOMONAS EXOTOXIN;
RECOMBINANT MONOCLONAL ANTIBODY HER 2;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
ANTIGEN ANTIBODY REACTION;
ANTIGEN EXPRESSION;
ANTINEOPLASTIC ACTIVITY;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG POTENTIATION;
GENE TARGETING;
HUMAN;
IMMUNOGENICITY;
PRIORITY JOURNAL;
PROTEIN TARGETING;
TUMOR IMMUNITY;
VACCINE PRODUCTION;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIBODIES, MONOCLONAL;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CANCER VACCINES;
DRUGS, INVESTIGATIONAL;
HUMANS;
IMMUNOTOXINS;
NEOPLASMS;
|
|
EID: 0030964090
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (27)
|
|
References (120)
|
